Sexually Transmitted Diseases Testing Devices Market

Sexually Transmitted Diseases Testing Devices Market contains market size and forecasts of Sexually Transmitted Diseases (STDs) Testing Devices in global, including the following market information:
Global Sexually Transmitted Diseases (STDs) Testing Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sexually Transmitted Diseases (STDs) Testing Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Sexually Transmitted Diseases (STDs) Testing Devices companies in 2021 (%)
The global Sexually Transmitted Diseases (STDs) Testing Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Thermal Cyclers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sexually Transmitted Diseases (STDs) Testing Devices include Roche Diagnostics, BioMerieux, Hologic, Inc., Becton Dickinson & Company, Cepheid, Inc., Danaher Corporation, Affymetrix, Inc., Alere, Inc. and Abbott Laboratories and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sexually Transmitted Diseases (STDs) Testing Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sexually Transmitted Diseases (STDs) Testing Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Sexually Transmitted Diseases (STDs) Testing Devices Market Segment Percentages, by Type, 2021 (%)
Thermal Cyclers
Lateral Flow Readers
Flow Cytometers
Differential Light Scattering Machines
Others
Global Sexually Transmitted Diseases (STDs) Testing Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Sexually Transmitted Diseases (STDs) Testing Devices Market Segment Percentages, by Application, 2021 (%)
Laboratory Testing
Point of Care Testing
Global Sexually Transmitted Diseases (STDs) Testing Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Sexually Transmitted Diseases (STDs) Testing Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sexually Transmitted Diseases (STDs) Testing Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sexually Transmitted Diseases (STDs) Testing Devices revenues share in global market, 2021 (%)
Key companies Sexually Transmitted Diseases (STDs) Testing Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Sexually Transmitted Diseases (STDs) Testing Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Diagnostics
BioMerieux
Hologic, Inc.
Becton Dickinson & Company
Cepheid, Inc.
Danaher Corporation
Affymetrix, Inc.
Alere, Inc.
Abbott Laboratories
DiaSorin